University of Ioannina
Η συμβολή του σπινθηρογραφήματος αιμάτωσης του μυοκαρδίου με Tc-99m (tetrofosmin) στην πρόγνωση μείζονων καρδιακών συμβαμάτων (έμφαση στον γυναικείο πληθυσμό)
Abstract
dc:descriptionINTRODUCTION: Cardiovascular disease is the leading cause of death in Europe (~ 20% of all causes). Despite the need for effective strategies for assessing prognosis in patients with known or suspected CKD, little data has been collected so far with standard diagnostic methods. Myocardial perfusion imaging (MPS) with single photon emission computed tomography (MPS SPECT) for scintigraphy is an established method of collecting both diagnostic and prognostic information in patients with known or suspected cardiac problems, and its appropriateness and accuracy have been tested. various subpopulations. Recent studies support the great utility of MPS SPECT for the prognostic stratification and selection of the optimal treatment of patients. PURPOSE: The primary objective of this dissertation is to investigate the incidence of cardiac events in patients undergoing myocardial perfusion imaging / MPS SPECT with technetium [99mTc tetrofosmin (99mTc-TF)] and if the secondary aim is to are a prognostic factor for the occurrence of heart events in the next twelve months. METHODOLOGY: The collection of clinical data of patients who underwent myocardial perfusion imaging (MPS SPECT) with 99mTc-TF was performed in two phases during the period from 01/01/2017 to 31/12/2017 in the Laboratory of Nuclear Medicine of the UHI. The first was done before the administration of the radiopharmaceutical. Twelve months after the imaging in the telephone communication of the researcher with the patient or with a person in his immediate environment (in case of weakness) data were recorded regarding the cardiac events that occurred. The duration of the study was a total of four years.Data from 1,025 patients who underwent MPS SPECT during the aforementioned period were initially collected. Complete follow-up data were collected for 998 patients (response rate 97.4%) and therefore, the final analysis was limited to these patients.The examination procedure included the preparation of the patient, protocols of the patient's medication or physical fatigue for the needs of MPSSPECT. Prior to fatigue, in addition to the patient's data, some clinical data were recorded, such as the indication for the scintigraphic study, and the SN-related risk factors. After one year the following data were collected: existence of a new MPS SPECT imaging, coronary angiography, reperfusion, death, acute myocardial infarction (non-fatal) and stroke (non-fatal). The findings of the MPS SPECT imaging were classified into the following categories of metabolic equivalents (METs): 1) normal respiration during fatigue and resting period, 2) normal respiration during resting period only, 3) respiration problems during fatigue and rest and 4) lack of radiopharmaceutical administration in the heart. RESULTS: The mean age of the participants was 67 years, of whom 64.7% were males and 17.8% were smokers. Results obtained from MPS SPECT reported that 83.6% of patients had abnormal myocardial perfusion, 44.4% presented indication of reversible deficits, 28.7% showed mixed deficits and 9.5% exhibited permanent deficits. Regarding the severity of LV perfusion deficits, in 59.5% of individuals this was described as small / medium whilst in 23% of patients, a large grade of LV perfusion deficit was observed. Following SPECT reperfusion, 22.1% of individuals underwent coronary angiography and interestingly, 89.5% of those were not diagnosed with CAD. Regarding the baseline outcomes, it was found that 8.1% experienced reperfusion after coronary angiography, 2.9% of patients died, 2.2% had non-fatal acute myocardial infarction and 2.9% had non-fatal cerebrovascular event. Additionally, a total of 14.63% was diagnosed with severe heart condition. Furthermore, comparison of myocardial perfusion with baseline outcomes showed that; 1) women without normal myocardial perfusion had an increased risk of referral for reperfusion and MACE and 2) patients with or without known CAD had an increased risk of referral for reperfusion. Comparison of type of abnormal perfusion with baseline outcomes showed that; 1) women with reversible ischemia are more likely to be subjected to reperfusion after coronary angiography and acute myocardial infarction (non-fatal). Patients without CAD with mixed deficits or patients with reversible ischemia are more likely to develop MACE or to undergo reperfusion after coronary angiography. Patients with cerebrovascular event with both reversible ischemia and mixed deficits are much more likely to undergo reperfusion. Comparison of the grade of LV perfusion deficits with baseline outcomes showed that both male and female patients with a high grade of LV perfusion deficits have significantly higher chances of being referred for reperfusion as well as MACE. Patients with or without CAD and with a high grade of LV perfusion deficits are much more likely to undergo reperfusion and develop MACE. Comparison of left ventricular dilatation with baseline outcomes showed that: patients without CAD and with left ventricular dilatation are much more likely to undergo reperfusion after coronary angiography as well as to develop MACE. The differences in the patients’ outcomes and results of MPS SPECT according to the risk factors showed that: Mortality is more likely to occur in individuals with diabetes, mixed deficits, BMI <25 and cardiac hypertrophy, whilst heredity and dyslipidemia were not classified as fatal risk factors. Additionally, left ventricular dilatation was reported as a significant factor contributing to the incidence of death. In particular, a patient who does not smoke is more likely to develop acute myocardial infarction (non-fatal) if he has mixed deficits, extensive myocardial infarction, dyslipidemia, regardless of hypertension, diabetes mellitus, obesity, hereditary history of CAD. Furthermore, it was found that patients who do not smoke are more likely to undergo reperfusion if they present pathological myocardial perfusion or if they suffer from hypertension and have a BMI of 25-29.9 or 30-34.9. Also, the probability of reperfusion is higher in those who have reversible ischemia or mixed deficits with hypertension, diabetes mellitus and BMI 25-29.9 regardless of CAD heredity. In addition, patients with a high grade of LV perfusion deficits have a significantly higher risk of reperfusion if they are non-smokers, or ex-smokers (>1 year), have a BMI of 25-29.9 or 30-34.9, regardless of dyslipidemia, hypertension, diabetes mellitus and hereditary. With regard to cerebrovascular event (non-fatal), a patient who does not have dyslipidemia, diabetes mellitus and hereditary history of CAD is more likely to develop non-fatal cerebrovascular event if they have stable deficits regardless of smoking, hypertension, obesity. Regarding MACE, a non-smoking patient is more likely to develop MACE if they have abnormal myocardial perfusion, hypertension, a BMI of 25-29.9 or 30-34.9, or mixed deficits regardless of dyslipidemia, diabetes mellitus and hereditary CAD. However, in patients with hypertension and BMI 25-29.9 the likelihood of MACE is higher in those with reversible ischemia or mixed deficits. Patients with a large grade of LV perfusion deficits have a significantly higher risk of developing MACE and finally, whether or not a patient presents with MACE depends on the distension of the abdominal left ventricular (LV) and is greater when the patient has a BMI <25 or> 35. CONCLUSIONS: Here it was concluded that MPS SPECT is a useful method for the assessment of CAD progression, as it can provide valuable information regarding the incidence of adverse heart attacks in patients with known or suspected cardiovascular problems. Overall, it was shown that most patients had abnormal myocardial perfusion and mainly reversible ischemia with low / moderate grade of LV perfusion deficits. A low percentage of patients had left ventricular dilatation. Equally low were the rates of patients with cardiac events after MPS SPECT, namely reperfusion, death, acute myocardial infarction non-fatal and cerebrovascular event non-fatal, while about 1 in 100 patients was diagnosed with a major cardiac event. Mortality was found to be intrigued by mixed deficits, large myocardial infarction, left ventricular dilatation, obesity, and diabetes mellitus. Non-fatal acute myocardial infarction appeared to be affected by mixed deficits and large myocardial extent. Myocardial rebleeding has been shown to be affected by mixed deficits or reversible ischemia, extensive large grade of LV perfusion deficits, hypertension, diabetes mellitus and obesity. Non-fatal cerebrovascular event appeared to be affected by persistent deficits and not to suffer from dyslipidemia, diabetes mellitus and a hereditary history of CAD. MACE has been shown to be affected by mixed deficits or reversible ischemia, extensive large grade of LV perfusion deficits, abdominal distension, smoking, hypertension, and obesity.
Degree
thesis:*- Grantor dc:publisher
- University of Ioannina
- Year dc:date
- 2021
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Zotou, Paraskevi
- Ζώτου, Παρασκευή
Subjects
dc:subject × 12Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/50448